共 6 条
[1]
Ezetimibe/Simvastatin vs Atorvastatin in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia: The VYTAL Study[J] . Ronald B. Goldberg,John R. Guyton,Theodore Mazzone,Ruth S. Weinstock,Adam Polis,Patricia Edwards,Joanne E. Tomassini,Andrew M. Tershakovec.Mayo Clinic Proceedings . 2006 (12)
[2]
Niemann–Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine[J] . Caroline Duval,Véronique Touche,Anne Tailleux,Jean-Charles Fruchart,Catherine Fievet,Véronique Clavey,Bart Staels,Sophie Lestavel.Biochemical and Biophysical Research Communications . 2006 (4)
[3]
The Second United Kingdom Heart and Renal Protection （UK-HARP-II） Study: A Randomized Controlled Study of the Biochemical Safety and Efficacy of Adding Ezetimibe to Simvastatin as Initial Therapy Among Patients With CKD[J] . Martin Landray,Colin Baigent,Craig Leaper,Dwomoa Adu,Paul Altmann,Jane Armitage,Simon Ball,Alex Baxter,Lisa Blackwell,Hugh S. Cairns,Sue Carr,Rory Collins,Karen Kourellias,Mary Rogerson,John E. Scoble,Charles R.V. Tomson,Graham Warwick,David C. Wheeler.American Journal of Ki
[4]
Dose-comparison study of the combination of ezetimibe and simvastatin （Vytorin） versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin （VYVA） Study[J] . Christie M. Ballantyne,Nicola Abate,Zhong Yuan,Thomas R. King,Joanne Palmisano.American Heart Journal . 2005 (3)
[5]
The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys[J] . Margaret van Heek,Douglas S Compton,Harry R Davis.European Journal of Pharmacology . 2001 (1)
[6]
ACAT2deficiency limits cholesterol absorption in the cholesterol-fed mouse:impact on hepat-ic cholesterol homeostasis. Repa JJ,Buhman KK,Farese RV,et al. Hepatology . 2004